Analyst consensus rating

INmune Bio Analyst Rating: Strong Buy

Direct answer

INmune Bio's consensus rating is Strong Buy.

3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.50.
Forecast evidence checked November 16, 2026.

Get free INmune Bio email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.05
Average price target
$6.50
High price target
$9.00
Low price target
$2.50
Low target gap
+138.1%
Target upside
+519%
High target gap
+757.1%
Target range width
619%
Consensus rating
Strong Buy
Analysts
3
Evidence date
November 16, 2026
Valid through
November 23, 2026

Read the frequently asked questions.

What is the analyst consensus rating for INmune Bio?

INmune Bio has a verified Strong Buy consensus. The same dataset has an average price target of $6.50.

How far are INmune Bio's low and high targets from the recorded price?

The low target implies +138.1%, while the high target implies +757.1%.

How many analysts are included in INmune Bio's consensus?

The verified consensus includes 3 analysts.

How is INmune Bio's target upside or downside calculated?

The average target of $6.50 is divided by the recorded price of $1.05, then one is subtracted to produce +519%. This does not guarantee a future return.

When was INmune Bio's analyst forecast verified?

The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.